BioSpace News Archive

Be Biopharma, Inc., a company pioneering the discovery and development of Engineered B Cell Medicines, will present first-of-its-kind preclinical research from a collaboration study showing homing and engraftment of B cells in non-human primates with intact immune systems.

2seventy bio, Inc. announced late-breaking results from the ongoing Phase 1 PLAT-08 trial, in collaboration with Seattle Children’s Therapeutics, evaluating SC-DARIC33 in relapsed or refractory pediatric and young adult AML patients, as well as an oral presentation evaluating regulated IL-15 production combined with DARIC33 activation for anti-AML potency.

First clinical trial reporting results of an mRNA therapeutic for intracellular protein replacement.

STRATA Skin Sciences, Inc. today announced Joel L. Cohen, MD (FAAD, FACMS), Director of AboutSkin Dermatology in Greenwood Village, Colorado will be demonstrating the TheraClear ® X device at the Music City Scale Symposium for Cosmetic Advances and Laser Education at the Grand Hyatt.

PaceMate ® announced today its collaboration with AliveCor ® , the global leader in FDA-cleared personal electrocardiogram technology and remote patient management solutions for the cardiovascular industry.

Enveric Biosciences, Inc. today announced its participation in this year’s 2023 BIO International Convention, which is being held in Boston, MA, June 5-8, 2023.

Augmedix Inc. today announced that its leadership team will attend the following investor conferences during May and June 2023.

Stereotaxis (NYSE: STXS) today announced a global collaboration with Abbott (NYSE: ABT) to integrate Abbott’s EnSite™ X EP System with Stereotaxis’ Robotic Magnetic Navigation systems.